Controlled Attenuation Parameter (CAP) for the detection of hepatic steatosis in alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD)

被引：0
|
作者：
Naveau, Sylvie [1 ]
Perlemuter, Gabriel [1 ]
Ziol, Marianne [4 ]
Carmona, Damien [3 ]
Trinchet, Jean Claude [3 ]
Prevot, Sophie [2 ]
Nohra, Pascal [1 ]
Nguefang-Njike, Micheline Nakseu [1 ]
Beaugrand, Michel [3 ]
机构：
[1] Hop Antoine Beclere, Gastroenterol Unit, Clamart, France
[2] Hop Antoine Beclere, Pathol Unit, Clamart, France
[3] Hop Jean Verdier, Gastroenterol Unit, Bondy, France
[4] Hop Jean Verdier, Pathol Unit, Bondy, France
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1506
引用
收藏
页码：898A / 898A
页数：1
相关论文
共 50 条
  • [1] Controlled Attenuation Parameter for detection and stadification of hepatic steatosis in alcoholic and non alcoholic fatty liver disease
    Lepida, Antonia
    Puleo, Francesco
    Degre, Delphine
    Verset, Laurine
    Demetter, Pieter
    Gustot, Thierry
    Bocci, Massimo
    Schreiber, Jonas
    Adler, Michael
    Trepo, Eric
    Moreno, Christophe
    [J]. HEPATOLOGY, 2013, 58 : 509A - 509A
  • [2] Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease
    de Ledinghen, Victor
    Wong, Grace Lai-Hung
    Vergniol, Julien
    Chan, Henry Lik-Yuen
    Hiriart, Jean-Baptiste
    Chan, Anthony Wing-Hung
    Chermak, Faiza
    Choi, Paul Cheung-Lung
    Foucher, Juliette
    Chan, Carmen Ka-Man
    Merrouche, Wassil
    Chim, Angel Mei-Ling
    Le Bail, Brigitte
    Wong, Vincent Wai-Sun
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (04) : 848 - 855
  • [3] Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)
    Choudhary, Narendra Singh
    Duseja, Ajay
    [J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 6
  • [4] STEATOSIS ASSESSMENT BY CAP™ IN PATIENTS WITH ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE
    Beaugrand, Michel
    Carmona, Damien
    Ziol, Marianne
    Perlemuter, Gabriel
    Naveau, Sylvie
    Prevot, Sophie
    Fournier, Celine
    Sandrin, Laurent
    Miette, Veronique
    Sasso, Magali
    [J]. HEPATOLOGY, 2011, 54 : 1147A - 1147A
  • [5] Diagnostic accuracy for non-alcoholic fatty liver disease (NAFLD) with controlled attenuation parameter (CAP) measured by transient elastography
    Kikuchi, Masahiro
    Umeda, Rumiko
    Tsuruya, Kota
    Shiozawa, Hirokazu
    Kikuchi, Miho
    Takahashi, Masahiko
    Horie, Yoshinori
    Nishizaki, Yasuhiro
    [J]. HEPATOLOGY, 2015, 62 : 1269A - 1269A
  • [6] Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Nier, Anika
    Huber, Yvonne
    Labenz, Christian
    Michel, Maurice
    Bergheim, Ina
    Schattenberg, Joern M.
    [J]. NUTRIENTS, 2020, 12 (03)
  • [7] Usefulness of controlled attenuation parameter in monitoring clinically relevant decline of hepatic steatosis for non-alcoholic fatty liver disease
    Wang, Jing-Houng
    Ou, Hsin-You
    Yen, Yi-Hao
    Hung, Chao-Hung
    Lu, Sheng-Nan
    [J]. LIVER INTERNATIONAL, 2023, 43 (09) : 1901 - 1908
  • [8] Performance of controlled attenuation parameter (CAP) to assess steatosis in a large prospective multicentre UK study of patients with non-alcoholic fatty liver disease (NAFLD)
    Eddowes, P.
    Allison, M.
    Tsochatzis, E.
    Anstee, Q.
    Sheridan, D.
    Guha, I. N.
    Cobbold, J.
    Paradis, V.
    Bedossa, P.
    Newsome, P.
    [J]. JOURNAL OF HEPATOLOGY, 2018, 68 : S98 - S98
  • [9] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
  • [10] Use of a controlled attenuation parameter for the diagnosis of non-alcoholic fatty liver disease
    Goncharov, Alexey A.
    Sasunova, Armida N.
    Pilipenko, Vladimir I.
    Isakov, Vasily A.
    [J]. TERAPEVTICHESKII ARKHIV, 2023, 95 (08): : 641 - 647
12345